Ingevity Corp (NGVT) stock
NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3073% above fair value
$61.72−0.25 (-0.40%)
Close on Nov 13, 2026Market cap $2.12BP/E 36.3Yield –
Ingevity enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Ingevity's enterprise value was $3.28B on Nov 11, 2026, against $3.06B a year earlier. Over the last 5 years it ranged from $2.53B to $4.47B, with a median of $3.35B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.28B | -0.8% |
| 2025 | Dec 31, 2025 | $3.31B | +16.4% |
| 2024 | Dec 31, 2024 | $2.84B | -8.2% |
| 2023 | Dec 29, 2023 | $3.10B | -16.5% |
| 2022 | Dec 30, 2022 | $3.71B | -3.0% |
| 2021 | Dec 31, 2021 | $3.83B | -9.5% |
| 2020 | Dec 31, 2020 | $4.23B | -13.7% |
| 2019 | Dec 31, 2019 | $4.90B | +16.4% |
| 2018 | Dec 31, 2018 | $4.21B | +25.0% |
| 2017 | Dec 29, 2017 | $3.36B | +19.8% |
| 2016 | Dec 30, 2016 | $2.81B | – |
See a number that looks wrong?